Showing results (1-10 of 2,685) with videos related to
Sort By:
Pageof 269
Arteriosclerosis, Thrombosis, and Vascular Biology|March 28, 2020
Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic AcidR Preston Mason, Peter Libby, Deepak L BhattEuropean Heart Journal|May 13, 2025
Acute coronary syndromes: mechanisms, challenges, and new opportunitiesSimon Kraler, Christian Mueller, Peter Libby, et al.European Journal of Preventive Cardiology|July 3, 2026
Rethinking triglycerides in the management of ASCVDShaun Khanna, Deepak L Bhatt, Peter Libby, et al.Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 11, 2022
A biological rationale for the disparate effects of omega-3 fatty acids on cardiovascular disease outcomesSamuel C R Sherratt, Peter Libby, Deepak L Bhatt, et al.Progress in Cardiovascular Diseases|August 22, 2021
The role of eicosapentaenoic acid in reducing important cardiovascular events, including coronary revascularizationRam D Bhatt, Peter Libby, Subodh Verma, et al.Journal of the American Heart Association|July 3, 2024
Eicosapentaenoic Acid Improves Endothelial Nitric Oxide Bioavailability Via Changes in Protein Expression During InflammationSamuel C R Sherratt, Peter Libby, Hazem Dawoud, et al.JACC. Advances|February 15, 2025
Potential Impact of Colchicine on Atherosclerotic Cardiovascular Disease in the United StatesLeo F Buckley, Bhavya Chebrolu, Mohsen Al Zaria, et al.Cardiovascular Research|August 25, 2025
Eicosapentaenoic acid (EPA) limits the more rapid oxidation of lipoprotein(a) [Lp(a)] compared with other ApoB particlesSamuel C R Sherratt, Peter Libby, Richard L Dunbar, et al.Current Atherosclerosis Reports|December 29, 2022
Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate ContinuesSamuel C R Sherratt, Peter Libby, Matthew J Budoff, et al.Cardiovascular Research|January 22, 2024
Do patients benefit from omega-3 fatty acids?Samuel C R Sherratt, R Preston Mason, Peter Libby, et al.Pageof 269